Baxter International, an American healthcare company, has received market approval in Europe for HOMECHOICE CLARIA, an automated peritoneal dialysis (APD) system.
The system is integrated with the SHARESOURCE web-based connectivity platform. According to the developer, the APD system is designed with user-friendly features and with secure two-way connectivity. The connectivity will help healthcare providers to monitor their patients' home peritoneal dialysis (PD) treatments and adjust prescriptions as necessary.
PD is a therapy option performed primarily at home by end-stage renal disease patients.
"CLARIA builds upon our market-leading HOMECHOICE APD device with new features to make the system more intuitive for patients to operate in their home and while traveling. Additionally, SHARESOURCE, the system's web-based platform, provides physicians remote access to their home patients' treatment information allowing for more timely and personalized care," said Bruce Culleton, M.D., vice president and renal therapeutic area lead at Baxter.
Baxter plans to initiate the commercial launch of the automated dialysis system in select European and Asian countries in the first half of 2015.
"Every patient with end-stage renal disease deserves access to individualized care. HOMECHOICE CLARIA with SHARESOURCE represents Baxter's continued commitment to advancing renal technology that offers healthcare providers and patients therapy options for end-stage renal disease," said Jill Schaaf, president of Baxter's Renal business.